# Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386

> **NCT00672646** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 103 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** AZD1386
- **DRUG:** Naproxen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00672646
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2012-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00672646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00672646, "Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00672646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*